Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-26

FDA Approved: DESOGESTREL AND ETHINYL ESTRADIOL — Supplemental Application (Mayne Pharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for Mayne Pharma Inc.'s Desogestrel and Ethinyl Estradiol tablets (ANDA 091234).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DESOGESTREL AND ETHINYL ESTRADIOL (DESOGESTREL AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for DESOGESTREL AND ETHINYL ESTRADIOL (DESOGESTREL AND ETHINYL ESTRADIOL)